Journals / The Turkish Journal of Ear Nose and Throat / 2010 / Cilt: 20 - Sayı: 2

Topical hemostatic agents in otolaryngologic surgery

Kulak burun boğaz ve baş boyun cerrahisinde topikal hemostatik ajanlar

Pages
100–109
Publication Date
2010-03-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper reviews traditional and newer topical hemostatic agents with regard to their chemical properties, their mechanisms of action, and the benefits and complications of topical agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Topical hemostatic agents are largely used to reduce blood loss during otolaryngologic surgery.
📊
Key Findings & Data:These agents play an important role in both keeping the patient’s hemodynamic equilibrium and allowing for a better view of the surgical field.
💡
Conclusion & Impact:This paper reviews traditional and newer topical hemostatic agents with regard to their chemical properties, their mechanisms of action, and the benefits and complications of topical agents.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kanama · lokal hemostaz · kulak burun boğaz ve baş boyun cerrahisi

Abstract

Topical hemostatic agents are largely used to reduce blood loss during otolaryngologic surgery. These agents play an important role in both keeping the patient’s hemodynamic equilibrium and allowing for a better view of the surgical field. These agents can be classified based on their mechanism of action, and include physical or mechanical agents. Most complications of topical hemostatic agents are sustained because of the antigenic reaction of those products. This paper reviews traditional and newer topical hemostatic agents with regard to their chemical properties, their mechanisms of action, and the benefits and complications of topical agents.

Özet

Topikal hemostatik ajanlar kulak burun boğaz ve baş boyun cerrahisinde kan kaybını azaltmak için yaygın olarak kullanılmaktadır. Bu ajanlar hem hastanın hemodinamisinin bozulmasını engel- ler hem de daha iyi cerrahi görüş alanı sağlar. Bu ajanlar etki mekanizmalarına göre fiziksel ve kimyasal ajanlar olarak sınıflanabilir. Topikal hemostatik ajanların en sık komplikasyonlarının bu ürünlerin antijenik reaksiyona neden olmaların- dan kaynaklandığı öne sürülmektedir. Bu yazıda geleneksel ve yeni topikal hemostatik ajanların kimyasal özellikleri, etki mekanizmaları, fayda ve yan etkileri derlenmiştir

🔖

Cite This Article

ACAR, B., BABADEMEZ, M. A., KARABULUT, H. (2010). Topical hemostatic agents in otolaryngologic surgery. The Turkish Journal of Ear Nose and Throat, Cilt: 20 - Sayı: 2, 100–109. https://ajindex.com/articles/727095

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Zwischenberger JB, Brunston RL Jr, Swann JR, Conti VR. Comparison of two topical collagen-based hemo- static sponges during cardiothoracic procedures. J Invest Surg 1999;12:101-6.
  2. Tan SR, Tope WD. Effectiveness of microporous polysaccharide hemospheres for achieving hemosta- sis in mohs micrographic surgery. Dermatol Surg 2004;30:908-14. Levy JH. Hemostatic agents. Transfusion. 2004; 44(12 Suppl): 58-62.
  3. Landry JR, Kanat IO. Considerations in topical hemo- stasis. J Am Podiatr Med Assoc 1985;75:581-5.
  4. Arand AG, Sawaya R. Intraoperative chemical hemo- stasis in neurosurgery. Neurosurgery 1986;18:223-33.
  5. Wagner WR, Pachence JM, Ristich J, Johnson PC. Comparative in vitro analysis of topical hemostatic agents. J Surg Res 1996;66:100-8. Cushing H. Electrosurgery as an aid to the removal of intracranial tumors: with a preliminary note on a new surgical-current generator by W T Bovie. Surg Gynecol Obstet 1928;47:751-84.
  6. Tan TC, Black PM. Sir Victor Horsley (1857-1916): pioneer of neurological surgery. Neurosurgery 2002; 50:607-11. Stone JL. Sir Charles Ballance: pioneer British neuro- logical surgeon. Neurosurgery 1999;44:610-31. Tomizawa Y. Clinical benefits and risk analysis of topi- cal hemostats: a review. J Artif Organs 2005;8:137-42. Hait MR. Microcrystalline collagen. A new hemostatic agent. Am J Surg 1970;120:330. Low WK, Sim CS. Bone wax foreign body granuloma in the mastoid. ORL J Otorhinolaryngol Relat Spec 2002;64:38-40. Allison RT. Foreign body reactions and an associated histological artefact due to bone wax. Br J Biomed Sci 1994;51:14-7.
  7. Howard TC, Kelley RR. The effect of bone wax on the healing of experimental rat tibial lesions. Clin Orthop Relat Res 1969;63:226-32.
  8. Patel PM, Blackburn TP, Chitnavis BP. Syringe tip accuracy for application of Victor Horsley’s bone wax. Br J Neurosurg 2003;17:546. Hadeishi H, Yasui N, Suzuki A. Mastoid canal and migrated bone wax in the sigmoid sinus: technical report. Neurosurgery 1995;36:1220-3.
  9. Pope LE, Hobbs CG. Epistaxis: an update on current management. Postgrad Med J 2005;81:309-14.
  10. Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg 2008;34:431-45.
  11. Murthy P, Laing MR. An unusual, severe adverse reaction to silver nitrate cautery for epistaxis in an immunocompromised patient. Rhinoloy 1996;34:186-7.
  12. Mayall F, Wild D. A silver tattoo of the nasal mucosa after silver nitrate cautery. J Laryngol Otol 1996; 110:609-10. Larson PO. Topical hemostatic agents for dermatologic surgery. J Dermato